Suppr超能文献

Cullin 3 E3 连接酶在肿瘤发生中的功能分析。

Functional analysis of Cullin 3 E3 ligases in tumorigenesis.

机构信息

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):11-28. doi: 10.1016/j.bbcan.2017.11.001. Epub 2017 Nov 8.

Abstract

Cullin 3-RING ligases (CRL3) play pivotal roles in the regulation of various physiological and pathological processes, including neoplastic events. The substrate adaptors of CRL3 typically contain a BTB domain that mediates the interaction between Cullin 3 and target substrates to promote their ubiquitination and subsequent degradation. The biological implications of CRL3 adaptor proteins have been well described where they have been found to play a role as either an oncogene, tumor suppressor, or can mediate either of these effects in a context-dependent manner. Among the extensively studied CRL3-based E3 ligases, the role of the adaptor protein SPOP (speckle type BTB/POZ protein) in tumorigenesis appears to be tissue or cellular context dependent. Specifically, SPOP acts as a tumor suppressor via destabilizing downstream oncoproteins in many malignancies, especially in prostate cancer. However, SPOP has largely an oncogenic role in kidney cancer. Keap1, another well-characterized CRL3 adaptor protein, likely serves as a tumor suppressor within diverse malignancies, mainly due to its specific turnover of its downstream oncogenic substrate, NRF2 (nuclear factor erythroid 2-related factor 2). In accordance with the physiological role the various CRL3 adaptors exhibit, several pharmacological agents have been developed to disrupt its E3 ligase activity, therefore blocking its potential oncogenic activity to mitigate tumorigenesis.

摘要

Cullin 3-RING 连接酶 (CRL3) 在调节各种生理和病理过程中发挥着关键作用,包括肿瘤发生事件。CRL3 的底物衔接子通常包含一个 BTB 结构域,该结构域介导 Cullin 3 与靶底物之间的相互作用,促进它们的泛素化和随后的降解。CRL3 衔接蛋白的生物学意义已经得到了很好的描述,它们被发现作为癌基因、肿瘤抑制因子发挥作用,或者在依赖于上下文的情况下介导这两种效应。在广泛研究的基于 CRL3 的 E3 连接酶中,衔接蛋白 SPOP(斑点型 BTB/POZ 蛋白)在肿瘤发生中的作用似乎依赖于组织或细胞的上下文。具体来说,SPOP 通过在许多恶性肿瘤中(尤其是前列腺癌)使下游癌蛋白不稳定而充当肿瘤抑制因子。然而,SPOP 在肾癌中主要发挥致癌作用。另一种经过充分研究的 CRL3 衔接蛋白 Keap1 可能在多种恶性肿瘤中作为肿瘤抑制因子发挥作用,主要是由于其对下游致癌底物 NRF2(核因子红细胞 2 相关因子 2)的特异性降解。根据各种 CRL3 衔接蛋白表现出的生理作用,已经开发了几种药理学药物来破坏其 E3 连接酶活性,从而阻断其潜在的致癌活性以减轻肿瘤发生。

相似文献

1
Functional analysis of Cullin 3 E3 ligases in tumorigenesis.
Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):11-28. doi: 10.1016/j.bbcan.2017.11.001. Epub 2017 Nov 8.
2
Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
Biomed Pharmacother. 2022 May;149:112882. doi: 10.1016/j.biopha.2022.112882. Epub 2022 Mar 29.
3
Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
Oncotarget. 2017 Jul 18;8(29):47890-47901. doi: 10.18632/oncotarget.18141.
4
Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP.
Acta Crystallogr D Biol Crystallogr. 2013 Sep;69(Pt 9):1677-84. doi: 10.1107/S0907444913012687. Epub 2013 Aug 15.
5
Cullin 3 and Its Role in Tumorigenesis.
Adv Exp Med Biol. 2020;1217:187-210. doi: 10.1007/978-981-15-1025-0_12.
6
The emerging role of SPOP protein in tumorigenesis and cancer therapy.
Mol Cancer. 2020 Jan 4;19(1):2. doi: 10.1186/s12943-019-1124-x.
7
Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.
Cancer Lett. 2017 Jan 28;385:207-214. doi: 10.1016/j.canlet.2016.10.021. Epub 2016 Oct 22.
8
CRL3s: The BTB-CUL3-RING E3 Ubiquitin Ligases.
Adv Exp Med Biol. 2020;1217:211-223. doi: 10.1007/978-981-15-1025-0_13.
9
The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer.
Biochem Biophys Res Commun. 2022 Dec 25;636(Pt 2):71-78. doi: 10.1016/j.bbrc.2022.10.108. Epub 2022 Nov 8.
10
Phosphorylation regulates cullin-based ubiquitination in tumorigenesis.
Acta Pharm Sin B. 2021 Feb;11(2):309-321. doi: 10.1016/j.apsb.2020.09.007. Epub 2020 Sep 19.

引用本文的文献

1
The role of ubiquitination and deubiquitination in urological tumours.
Front Pharmacol. 2025 Jul 23;16:1532878. doi: 10.3389/fphar.2025.1532878. eCollection 2025.
3
Advancements in the research of the structure, function, and disease-related roles of ARMC5.
Front Med. 2025 Apr;19(2):185-199. doi: 10.1007/s11684-024-1108-0. Epub 2025 Feb 17.
5
SPOP-mediated RIPK3 destabilization desensitizes LPS/sMAC/zVAD-induced necroptotic cell death.
Cell Mol Life Sci. 2024 Nov 14;81(1):451. doi: 10.1007/s00018-024-05487-7.
7
The CRL3 ubiquitin ligase-USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11.
Proc Natl Acad Sci U S A. 2024 Jul 9;121(28):e2320655121. doi: 10.1073/pnas.2320655121. Epub 2024 Jul 3.
8
Prognostic value and drug sensitivity of F‑box and leucine‑rich repeat protein 6 in glioma.
Oncol Lett. 2024 May 14;28(1):320. doi: 10.3892/ol.2024.14453. eCollection 2024 Jul.
10
SPOP point mutations regulate substrate preference and affect its function.
Cell Death Dis. 2024 Feb 26;15(2):172. doi: 10.1038/s41419-024-06565-1.

本文引用的文献

2
Klhl6 Deficiency Impairs Transitional B Cell Survival and Differentiation.
J Immunol. 2017 Oct 1;199(7):2408-2420. doi: 10.4049/jimmunol.1700708. Epub 2017 Aug 14.
5
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
Nat Med. 2017 Sep;23(9):1063-1071. doi: 10.1038/nm.4378. Epub 2017 Aug 14.
6
Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Gastroenterology. 2017 Nov;153(5):1429-1443.e5. doi: 10.1053/j.gastro.2017.07.036. Epub 2017 Jul 29.
7
Nrf2 as a target for prevention of age-related and diabetic cataracts by against oxidative stress.
Aging Cell. 2017 Oct;16(5):934-942. doi: 10.1111/acel.12645. Epub 2017 Jul 19.
8
The genetic landscape of endometrial clear cell carcinomas.
J Pathol. 2017 Oct;243(2):230-241. doi: 10.1002/path.4947. Epub 2017 Sep 5.
9
Ductal adenocarcinoma of the prostate: Clinical and biological profiles.
Prostate. 2017 Sep;77(12):1242-1250. doi: 10.1002/pros.23383. Epub 2017 Jul 12.
10
The see-saw of Keap1-Nrf2 pathway in cancer.
Crit Rev Oncol Hematol. 2017 Aug;116:89-98. doi: 10.1016/j.critrevonc.2017.02.006. Epub 2017 Feb 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验